SE8201337L - Polymeric matrix contg. ephedrine - for prolonged transdermal release to give decongestant effect - Google Patents

Polymeric matrix contg. ephedrine - for prolonged transdermal release to give decongestant effect

Info

Publication number
SE8201337L
SE8201337L SE8201337A SE8201337A SE8201337L SE 8201337 L SE8201337 L SE 8201337L SE 8201337 A SE8201337 A SE 8201337A SE 8201337 A SE8201337 A SE 8201337A SE 8201337 L SE8201337 L SE 8201337L
Authority
SE
Sweden
Prior art keywords
ephedrine
give
polymeric matrix
decongestant effect
transdermal release
Prior art date
Application number
SE8201337A
Other languages
Swedish (sv)
Other versions
SE447448B (en
Inventor
A D Keith
W Snipes
Original Assignee
Key Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/167,009 external-priority patent/US4289749A/en
Priority claimed from US06/167,729 external-priority patent/US4291014A/en
Application filed by Key Pharma filed Critical Key Pharma
Publication of SE8201337L publication Critical patent/SE8201337L/en
Publication of SE447448B publication Critical patent/SE447448B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Self-supporting polymeric diffusion matrix comprises 2-60% polar plasticiser (I), 6-20% polyvinyl alcohol (II), 2-10% polyvinylpyrrolidone (III) together with ephedrine (IV). The matrix is suitable for prolonged release of (IV) transdermally to achieve a decongestant effect. Dose is 5-30 mg. (IV) daily (i.e. lower than the usual oral dosage).
SE8201337A 1980-07-09 1982-03-04 POLYMER DIFFUSION MATRIX FOR TRANSDERMAL ADMINISTRATION OF MEDICINAL PRODUCTS SE447448B (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US16700880A 1980-07-09 1980-07-09
US06/167,009 US4289749A (en) 1979-08-14 1980-07-09 Polymeric diffusion matrix containing phenylpropanolamine
US06/167,104 US4292302A (en) 1979-08-14 1980-07-09 Polymeric diffusion matrix containing terbutaline
US06/167,010 US4292301A (en) 1979-08-14 1980-07-09 Polymeric diffusion matrix containing ephedrine
US06/167,101 US4294820A (en) 1979-08-14 1980-07-09 Polymeric diffusion matrix containing phenylephrine
US06/167,106 US4292303A (en) 1979-08-14 1980-07-09 Polymeric diffusion matrix containing clonidine
US06/167,729 US4291014A (en) 1979-01-11 1980-07-11 Polymeric diffusion matrix containing estradiol diacetate
US06/217,400 US4321252A (en) 1979-08-14 1980-12-17 Polymeric diffusion matrix containing ester derivatives of estradiol
PCT/US1981/000893 WO1982000099A1 (en) 1980-07-09 1981-06-26 Polymeric diffusion matrix for administration of drugs

Publications (2)

Publication Number Publication Date
SE8201337L true SE8201337L (en) 1982-03-04
SE447448B SE447448B (en) 1986-11-17

Family

ID=41698406

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8201337A SE447448B (en) 1980-07-09 1982-03-04 POLYMER DIFFUSION MATRIX FOR TRANSDERMAL ADMINISTRATION OF MEDICINAL PRODUCTS

Country Status (13)

Country Link
JP (1) JPS57500980A (en)
AU (1) AU7415181A (en)
BE (1) BE889549A (en)
CA (1) CA1163559A (en)
CH (1) CH658597A5 (en)
DE (1) DE3152182A1 (en)
FR (1) FR2486397A1 (en)
GB (1) GB2089210B (en)
IT (1) IT1237327B (en)
NL (1) NL8120270A (en)
NO (1) NO153638C (en)
SE (1) SE447448B (en)
WO (1) WO1982000099A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58206751A (en) * 1982-05-26 1983-12-02 日石三菱株式会社 Wound covering material
FR2532546B1 (en) * 1982-09-07 1985-12-27 Biotrol Sa Lab SKIN PROTECTION PASTE
FR2548021B1 (en) * 1983-06-29 1986-02-28 Dick P R PROLONGED AND CONTINUOUS DERMAL PHARMACEUTICAL COMPOSITIONS BASED ON ESSENTIAL FATTY ACIDS
DE3409079A1 (en) * 1984-03-13 1985-09-19 Bayer Ag, 5090 Leverkusen MEDICAL PLASTER
SE457326B (en) * 1986-02-14 1988-12-19 Lejus Medical Ab PROCEDURES FOR PREPARING A QUICK SUBSTANTIAL CANDLES CONTAINING BLA MICROCRISTALLIN CELLULOSA
US4860543A (en) * 1986-08-08 1989-08-29 Helix Technology Corporation Vibration isolation system for a linear reciprocating machine
SU1705319A1 (en) * 1987-10-23 1992-01-15 Всесоюзный Научно-Исследовательский Институт Биотехнологии Polymer diffuse matrix composition for transdermal drug introduction
IT1261305B (en) * 1993-06-22 1996-05-14 Gevipi Ag VIBRATION AND NOISE DAMPING DEVICE, FOR HYDRAULIC SYSTEMS
DE4429667C2 (en) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol TTS with water-binding additives and process for its preparation
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
AU2727801A (en) * 1999-12-16 2001-06-25 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
US6602912B2 (en) 2000-06-30 2003-08-05 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
US6719997B2 (en) 2000-06-30 2004-04-13 Dermatrends, Inc. Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2693438A (en) * 1951-02-21 1954-11-02 Norwich Pharma Co Preformed, nonadherent films for application to open lesions
US2804073A (en) * 1953-01-26 1957-08-27 Protective Teatments Inc Fluid surgical dressing
BE638231A (en) * 1962-03-16
US3214338A (en) * 1964-07-31 1965-10-26 Ehrlich Joseph Ronald Medicament releasing film-forming ointments and process of making
SU219116A1 (en) * 1965-11-26 1973-03-20 А. А. Вишневский, Т. Т. Даурова, М. И. Долгина, И. А. Паников, Ф. П. Сидельковска , М. И. Шрайбер FILM FOR PRIMARY PROCESSING OF THE BURN SURFACE
DE1617282A1 (en) * 1965-11-30 1975-02-06 Astra Pharma Prod DEVICE FOR LOCAL ANESTHETIZATION BY LOCAL APPLICATION AND METHOD FOR MANUFACTURING THIS DEVICE
GB1213295A (en) * 1967-04-27 1970-11-25 Boots Pure Drug Co Ltd Improvements in therapeutic compositions for topical application
FR2047874A6 (en) * 1969-06-10 1971-03-19 Nouvel Lucien
US3577516A (en) * 1969-12-02 1971-05-04 Nat Patent Dev Corp Preparation of spray on bandage
DE2012775C3 (en) * 1970-03-18 1973-10-04 V.P. Variopharm Gmbh Herstellung Und Vertrieb Pharmazeutischer, Kosmetischer Und Chemischer Erzeugnisse, 6656 Einoed Ointment foils and process for their manufacture
US3892905A (en) * 1970-08-12 1975-07-01 Du Pont Cold water soluble plastic films
US4210633A (en) * 1978-10-20 1980-07-01 Eli Lilly And Company Flurandrenolide film formulation
IL59063A (en) * 1979-01-11 1983-12-30 Key Pharma Polymeric diffusion matrix for release of pharmaceutical dosage

Also Published As

Publication number Publication date
AU7415181A (en) 1982-02-02
BE889549A (en) 1981-11-03
CH658597A5 (en) 1986-11-28
NO820722L (en) 1982-03-08
CA1163559A (en) 1984-03-13
NO153638C (en) 1986-05-07
JPS57500980A (en) 1982-06-03
NL8120270A (en) 1982-06-01
GB2089210B (en) 1984-09-05
IT8219833A0 (en) 1982-02-24
IT1237327B (en) 1993-05-31
WO1982000099A1 (en) 1982-01-21
SE447448B (en) 1986-11-17
DE3152182A1 (en) 1983-02-10
NO153638B (en) 1986-01-20
FR2486397A1 (en) 1982-01-15
GB2089210A (en) 1982-06-23

Similar Documents

Publication Publication Date Title
SE8201337L (en) Polymeric matrix contg. ephedrine - for prolonged transdermal release to give decongestant effect
JPS6468314A (en) Transdermal drug administration system containing two kind of permeation accelerators
ES8506186A1 (en) Sheet-shape adhesive preparation.
AU533491B2 (en) Bandage for administering drugs to the skin
ES2011185A6 (en) Skin permeation enhancer compositions using glycerol monooleate
DE68926169D1 (en) MEDICINE CONTAINING MEDICINE
ES2074513T3 (en) USE OF AN OPIACEOUS ANTAGONIST FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR TRANSDERMIC ADMINISTRATION AND A DEVICE FOR PERCUTANEOUS SUPPLY.
ES550011A0 (en) A METHOD OF ADMINISTRATION OF A THERAPEUTICALLY EFFECTIVE AMOUNT OF TIMOLOL
AU1023788A (en) Therapeutic system for sparingly soluble active ingredients
ES8307095A1 (en) Pharmaceutical Formulation.
AU585775B2 (en) Self controlled release device for administering beneficial agent to recipient
ES2011120A6 (en) Dosage form for treating cardiovascular diseases comprising isradipine
IL59063A (en) Polymeric diffusion matrix for release of pharmaceutical dosage
AU2916792A (en) Multilayer controlled release tablets containing both naproxen and naproxen sodium salt
GR3003289T3 (en) Drug-containing plaster of the sustained-release type
MX169815B (en) CHEWABLE MEDICATION TABLET CONTAINING MEANS TO MASK THE TASTE
NZ332215A (en) Transdermally administered dextromethorphan as antitussive agent
IE42950L (en) X-ray contrast preparations
DE3789258D1 (en) Delayed release multigranular tablet.
AU7071487A (en) Chlorpheniramine therapy
DE3271647D1 (en) Polymeric diffusion matrix containing propranolol
CA2234969A1 (en) Adhesive patch for lithium controlled release
ES8603262A1 (en) Oral solid pharmaceutical form with sequential action for the administering of drugs with ulcerogenic side effect.
SU990225A1 (en) Teeth acidic necrosis prophylaxis method
MY100518A (en) Trinitroglycerol sustained release vehicles and preparation therefrom.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8201337-6

Effective date: 19890725

Format of ref document f/p: F